A Study to Evaluate ABP 206 Compared With OPDIVO® (Nivolumab) in Subjects With Unresectable or Metastatic Melanoma

NCT ID: NCT06054555

This clinical trial is studying a new treatment called ABP 206 to see how it compares to an existing medication known as OPDIVO® (Nivolumab) for patients with advanced melanoma that cannot be surgi...

Recruiting

Phase: PHASE3 Type: interventional Locations: Valencia, Spain, Barcelona, Spain +394 more

Clinical Genetics Branch Eligibility Screening Survey

NCT ID: NCT07005297

The Clinical Genetics Branch (CGB) is looking for people to participate in research studies focused on specific genetic conditions that can increase the risk of cancer, such as melanoma and various...

Not yet recruiting

Type: observational Locations: Rockville, Maryland, United States

A Study to Learn About the Study Medicine Called PF-07799544 in People With Advanced Solid Tumors

NCT ID: NCT05538130

This clinical trial is studying a new medicine called PF-07799544 to see how safe and effective it is for people with advanced solid tumors, such as melanoma, brain cancer, thyroid cancer, and lung...

Recruiting

Phase: PHASE1 Type: interventional Locations: Boston, Massachusetts, United States, Detroit, Michigan, United States +53 more

A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.

NCT ID: NCT05355701

This clinical trial is studying a new medicine called PF-07799933 to see how safe it is and how well it works for people with advanced solid tumors that have a specific gene change known as a "BRAF...

Recruiting

Phase: PHASE1 Type: interventional Locations: Boston, Massachusetts, United States, Detroit, Michigan, United States +47 more

National Cancer Institute "Cancer Moonshot Biobank"

NCT ID: NCT04314401

The "Cancer Moonshot Biobank" is a clinical trial that aims to gather blood and tissue samples from patients diagnosed with various types of cancer, including advanced stages of breast cancer, lung...

Recruiting

Type: observational Locations: Des Moines, Iowa, United States, Scarborough, Maine, United States +181 more

Follow Up Protocol for Subjects Previously Enrolled on NCI Surgery Branch Studies

NCT ID: NCT00923026

This is a long-term follow-up study for people who previously took part in gene therapy trials run by the National Cancer Institute’s (NCI) Surgery Branch. There’s no new treatment being tested in ...

Enrolling by invitation

Type: observational Locations: Bethesda, Maryland, United States

PLUG-IN: Pembrolizumab Combined With Enfortumab Vedotin for Advanced Melanoma Patients

NCT ID: NCT06906822

The PLUG-IN trial is studying a new treatment approach for patients with advanced melanoma who have not responded to standard therapies. Specifically, it looks at combining two drugs: pembrolizumab...

Recruiting

Phase: PHASE2 Type: interventional Locations: Madrid, Spain, Madrid, Spain +11 more

A Study to Learn About the Long-Term Health of Adult Participants From a Previous Study of a New Melanoma Treatment

NCT ID: NCT06848088

This clinical trial is looking into the long-term health effects of two experimental drugs, fianlimab and cemiplimab, for adults who have advanced melanoma, a type of skin cancer. If you participat...

Enrolling by invitation

Phase: PHASE2 Type: interventional Locations: San Antonio, Texas, United States, Nashville, Tennessee, United States +1 more

GI-101 as a Single Agent or in Combination With Pembrolizumab, Lenvatinib or Local Radiotherapy in Advanced Solid Tumors

NCT ID: NCT04977453

This clinical trial is studying a new treatment called GI-101, which may be used alone or alongside other therapies like pembrolizumab, lenvatinib, or local radiotherapy. The main goal is to assess...

Recruiting

Phase: PHASE1 Type: interventional Locations: Huntersville, North Carolina, United States, Seoul, Korea, Republic Of +7 more

A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer

NCT ID: NCT05053230

The IM@HOME clinical trial is studying a program that offers virtual mind-body therapies to help people with certain types of cancer, including head and neck cancer, ovarian cancer, and melanoma, a...

Recruiting

Phase: NA Type: interventional Locations: New York, New York, United States, Basking Ridge, New Jersey, United States +5 more

Prospective Procurement of Tumor Tissue to Identify Novel Therapeutic Targets and Study the Tumor Microenvironment

NCT ID: NCT05600933

This is an observational study at the NIH Clinical Center to collect tumor tissue and blood from adults who are already having surgery or biopsy for known or suspected cancer. The goal is to learn ...

Enrolling by invitation

Type: observational Locations: Bethesda, Maryland, United States

Evaluation for NCI Surgery Branch Clinical Research Protocols

NCT ID: NCT00001823

This clinical trial, led by the National Cancer Institute Surgery Branch (NCI-SB), is exploring new experimental treatments for various types of cancer, including synovial cell cancer, melanoma, co...

Recruiting

Type: observational Locations: Bethesda, Maryland, United States

To Evaluate the Safety and Efficacy of ADP-TILIL7 in Patients With Locally Advanced or Metastatic Melanoma

NCT ID: NCT06204991

This clinical trial is investigating a new treatment called ADP-TILIL7 for patients with advanced melanoma, specifically those whose cancer cannot be surgically removed or has spread to other parts...

Recruiting

Phase: PHASE1 Type: interventional Locations: Herlev, Denmark

Study of GV20-0251 in Participants With Solid Tumor Malignancies

NCT ID: NCT07070518

This clinical trial is testing a new medicine called GV20-0251 to see if it can help adults with advanced solid tumors—types of cancer that form solid masses in the body—who have not responded to s...

Recruiting

Phase: PHASE1 Type: interventional Locations: Beijing, Beijing, China

A Study to Test How BI 765063 and BI 770371 Are Taken up in Tumours of People With Different Types of Advanced Cancer Who Are Also Taking Ezabenlimab

NCT ID: NCT05068102

This clinical trial is looking at how two medicines, BI 765063 and BI 770371, are taken up by tumors in adults with advanced types of cancer, such as head and neck cancer, melanoma, or non-small ce...

Recruiting

Phase: PHASE1 Type: interventional Locations: Amsterdam, Netherlands, Amsterdam, Netherlands

A Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7502175 as a Single Agent and in Combination With Checkpoint Inhibitor in Participants With Locally Advanced or Metastatic Solid Tumors

NCT ID: NCT05581004

This clinical trial is testing a new treatment called RO7502175, both on its own and in combination with another medication called atezolizumab. The study is designed for adults who have locally ad...

Recruiting

Phase: PHASE1 Type: interventional Locations: Detroit, Michigan, United States, Atlanta, Georgia, United States +46 more

A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors

NCT ID: NCT05208762

This clinical trial is studying a new drug called PF-08046054/SGN-PDL1V to see how safe it is for patients with advanced solid tumors, which are cancers that have spread in the body or cannot be su...

Recruiting

Phase: PHASE1 Type: interventional Locations: Iowa City, Iowa, United States, Milano, Italy +75 more

A Study to Learn About the Study Medicine Called PF-08046031 in Advanced Melanoma and Other Solid Tumors

NCT ID: NCT06799533

This clinical trial is studying a new medicine called PF-08046031, which is being tested for safety and effectiveness in treating advanced melanoma and other solid tumors. These are types of cancer...

Recruiting

Phase: PHASE1 Type: interventional Locations: San Francisco, California, United States, Pittsburgh, Pennsylvania, United States +13 more

A Study to Learn About the Study Medicine Called PF-08046032 in People With Advanced Cancers

NCT ID: NCT06870487

This clinical trial is designed to investigate a new medicine called PF-08046032 for adults with advanced cancers, specifically certain types of lymphomas and solid tumors. The study aims to unders...

Recruiting

Phase: PHASE1 Type: interventional Locations: Houston, Texas, United States, Barcelona, Spain +8 more

A Safety, Pharmacokinetic and Clinical Activity Study of NUC-7738 in Patients With Advanced Solid Tumours and Lymphoma

NCT ID: NCT03829254

This clinical trial is studying a new treatment called NUC-7738 for patients with advanced cancers, including solid tumors and lymphoma. The trial is divided into two phases. In the first phase, re...

Recruiting

Phase: PHASE1 Type: interventional Locations: London, United Kingdom, Newcastle, United Kingdom +9 more

Main Menu

Clinical Trials for Melanoma

253 Active Trials Found

A Study to Evaluate ABP 206 Compared With OPDIVO® (Nivolumab) in Subjects With Unresectable or Metastatic Melanoma

Clinical Genetics Branch Eligibility Screening Survey

A Study to Learn About the Study Medicine Called PF-07799544 in People With Advanced Solid Tumors

A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.

National Cancer Institute "Cancer Moonshot Biobank"

Follow Up Protocol for Subjects Previously Enrolled on NCI Surgery Branch Studies

PLUG-IN: Pembrolizumab Combined With Enfortumab Vedotin for Advanced Melanoma Patients

A Study to Learn About the Long-Term Health of Adult Participants From a Previous Study of a New Melanoma Treatment

GI-101 as a Single Agent or in Combination With Pembrolizumab, Lenvatinib or Local Radiotherapy in Advanced Solid Tumors

A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer

Prospective Procurement of Tumor Tissue to Identify Novel Therapeutic Targets and Study the Tumor Microenvironment

Evaluation for NCI Surgery Branch Clinical Research Protocols

To Evaluate the Safety and Efficacy of ADP-TILIL7 in Patients With Locally Advanced or Metastatic Melanoma

Study of GV20-0251 in Participants With Solid Tumor Malignancies

A Study to Test How BI 765063 and BI 770371 Are Taken up in Tumours of People With Different Types of Advanced Cancer Who Are Also Taking Ezabenlimab

A Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7502175 as a Single Agent and in Combination With Checkpoint Inhibitor in Participants With Locally Advanced or Metastatic Solid Tumors

A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors

A Study to Learn About the Study Medicine Called PF-08046031 in Advanced Melanoma and Other Solid Tumors

A Study to Learn About the Study Medicine Called PF-08046032 in People With Advanced Cancers

A Safety, Pharmacokinetic and Clinical Activity Study of NUC-7738 in Patients With Advanced Solid Tumours and Lymphoma

Related Conditions